Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958 · View on ClinicalTrials.gov ↗
Study Summary
Chromosomal analysis or the study of genetic differences in patients previously untreated with AML, ALL, MDS or MM may be helpful in the diagnosis and classification of disease. It may also improve the ability to predict the course of disease and the selection of therapy. Institutions must have either an Alliance-approved cytogeneticist or an agreement from an Alliance-approved main member cytogenetics laboratory to enroll a patient on CALGB 8461. The Alliance Approved Institutional Cytogeneticists list is posted on the Alliance for Clinical Trials in Oncology website.
Conditions Studied
Interventions
- GENETIC cytogenetic analysis
Study Locations (20)
Illinois
- Illinois CancerCare - Bloomington — Bloomington
- St. Joseph Medical Center — Bloomington
- Graham Hospital — Canton
- Illinois CancerCare - Canton — Canton
- Illinois CancerCare - Carthage — Carthage
- Memorial Hospital — Carthage
- University of Illinois Cancer Center — Chicago
- University of Chicago Cancer Research Center — Chicago
California
- Rebecca and John Moores UCSD Cancer Center — La Jolla
- Camino Medical Group - Treatment Center — Mountain View
- Kaiser Permanente Medical Office -Vandever Medical Office — San Diego
- Naval Medical Center - San Diego — San Diego
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco
Florida
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital — Fort Lauderdale
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center — Jupiter
- CCOP - Mount Sinai Medical Center — Miami Beach
Delaware
- Tunnell Cancer Center at Beebe Medical Center — Lewes
- CCOP - Christiana Care Health Services — Newark
District of Columbia
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C.
- Washington Cancer Institute at Washington Hospital Center — Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,000 participants |
| Start Date | 1984-06 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00048958
The ClinicalTrials.gov registry entry for NCT00048958 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 9,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 147 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention — of which cytogenetic analysis is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00048958 reports 20 study locations spanning 5 distinct geographic areas — top geographies include Illinois, California, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00048958 about?
NCT00048958 is a clinical study titled "Cytogenetic Studies in Acute Leukemia and Multiple Myeloma". Chromosomal analysis or the study of genetic differences in patients previously untreated with AML, ALL, MDS or MM may be helpful in the diagnosis and classification of disease. It may also improve the ability to predict the course of disease and the selection of therapy. Institutions must have eith...
What is the current status of trial NCT00048958?
This trial is currently active not recruiting. The enrollment target is 9,000 participants. The study started on 1984-06.
What conditions does trial NCT00048958 study?
This clinical trial studies the following conditions: Multiple Myeloma, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, Acute Leukemia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00048958?
The interventions under investigation include: cytogenetic analysis (GENETIC). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00048958?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 147 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00048958 being conducted?
This trial has 20 study locations across California, Delaware, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.